165 results on '"Guillot Loïc"'
Search Results
2. Airway infections as a risk factor for Pseudomonas aeruginosa acquisition and chronic colonisation in children with cystic fibrosis
3. Cryptococcus neoformans induces IL-8 secretion and CXCL1 expression by human bronchial epithelial cells
4. Risk factors for Pseudomonas aeruginosa airway infection and lung function decline in children with cystic fibrosis
5. FAM13A is a modifier gene of cystic fibrosis lung phenotype regulating rhoa activity, actin cytoskeleton dynamics and epithelial-mesenchymal transition
6. Cigarette smoke and electronic cigarettes differentially activate bronchial epithelial cells
7. Immune Response in Cystic Fibrosis: Interplay between the Host and Microbes
8. Translating the genetics of cystic fibrosis to personalized medicine
9. New Insights about miRNAs in Cystic Fibrosis
10. Effect of Flagellin Pre-Exposure on the Inflammatory and Antifungal Response of Bronchial Epithelial Cells to Fungal Pathogens
11. Modifier Factors of Cystic Fibrosis Phenotypes: A Focus on Modifier Genes
12. Développement d’un outil de comparaison de méthodes de comblement de lacune (gapfilling) sur les traits de plantes
13. Secretory phospholipase A2 expression and activity in preterm clinical chorioamnionitis with fetal involvement
14. Human Bronchial Epithelial Cells Inhibit Aspergillus fumigatus Germination of Extracellular Conidia via FleA Recognition
15. SLC6A14 Impacts Cystic Fibrosis Lung Disease Severity via mTOR and Epithelial Repair Modulation
16. Flagellin From Pseudomonas aeruginosa Modulates SARS-CoV-2 Infectivity in Cystic Fibrosis Airway Epithelial Cells by Increasing TMPRSS2 Expression
17. TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model
18. Editorial: Immune Responses of the Mucosal Epithelium in Chronic Lung Diseases
19. Moving beyond genetics: is FAM13A a major biological contributor in lung physiology and chronic lung diseases?
20. Additional file 1 of Cigarette smoke and electronic cigarettes differentially activate bronchial epithelial cells
21. Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?
22. Neutrophil Elastase Degrades Cystic Fibrosis Transmembrane Conductance Regulator via Calpains and Disables Channel Function In Vitro and In Vivo
23. Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in children
24. Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells
25. BAL Fluid Surfactant Protein C Level Is Related to Parenchymal Lung Disease in Children With Sarcoidosis
26. Flagellin from Pseudomonas aeruginosa modulates SARS-CoV-2 infectivity in CF airway epithelial cells by increasing TMPRSS2 expression
27. Bronchial Epithelial Cells on the Front Line to Fight Lung Infection-Causing Aspergillus fumigatus
28. Characteristics of disorders associated with genetic mutations of surfactant protein C
29. NKX2-1 Mutations Leading to Surfactant Protein Promoter Dysregulation Cause Interstitial Lung Disease in “Brain-Lung-Thyroid Syndrome”
30. Additional file 3: Table S2. of DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis
31. Additional file 2: Figure S2. of DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis
32. Additional file 5: Table S1. of DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis
33. SLC26A9 Gene Is Associated With Lung Function Response to Ivacaftor in Patients With Cystic Fibrosis
34. Bronchial Epithelial Cells from Cystic Fibrosis Patients Express a Specific Long Non-coding RNA Signature upon Pseudomonas aeruginosa Infection
35. DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis
36. Normal and Cystic Fibrosis Human Bronchial Epithelial Cells Infected with Pseudomonas aeruginosa Exhibit Distinct Gene Activation Patterns
37. Moving beyond genetics: isFAM13Aa major biological contributor in lung physiology and chronic lung diseases?
38. A NovelFOXE1Mutation (R73S) in Bamforth–Lazarus Syndrome Causing Increased Thyroidal Gene Expression
39. Alveolar epithelial cells: Master regulators of lung homeostasis
40. Glucocorticoids reduce inflammation in cystic fibrosis bronchial epithelial cells
41. Multiplex Ligation-Dependent Probe Amplification Improves the Detection Rate of NKX2.1 Mutations in Patients Affected by Brain-Lung-Thyroid Syndrome
42. Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in children
43. Macrolides: New therapeutic perspectives in lung diseases
44. Restoration of Chloride Efflux by Azithromycin in Airway Epithelial Cells of Cystic Fibrosis Patients
45. NKX2-1mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in “Brain-Lung-Thyroid Syndrome”
46. NOD2-Deficient Mice Have Impaired Resistance to Mycobacterium tuberculosis Infection through Defective Innate and Adaptive Immunity
47. Enhanced Innate Immune Responsiveness to Pulmonary Cryptococcus neoformans Infection Is Associated with Resistance to Progressive Infection
48. Cryptococcus neoformans induces IL-8 secretion and CXCL1 expression by human bronchial epithelial cells
49. Involvement of Toll-like Receptor 3 in the Immune Response of Lung Epithelial Cells to Double-stranded RNA and Influenza A Virus
50. Response of Human Pulmonary Epithelial Cells to Lipopolysaccharide Involves Toll-like Receptor 4 (TLR4)-dependent Signaling Pathways
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.